Figure 4. Cumulative survival of the hepatocellular carcinoma (HCC) patients by treatment in the two considered periods 2002–2006 (P1) and 2007–2011 (P2).
(A) Liver transplantation. (B) Surgical resection. (C) Transcatheter arterial chemoembolization (TACE). (D) Percutaneous local ablation. (E) Systematic therapy. (F) Supportive care. (G) Other therapy.